Free Trial

Allient (ALNT) Competitors

Allient logo
$24.64 +0.22 (+0.90%)
Closing price 02/4/2025 04:00 PM Eastern
Extended Trading
$24.64 0.00 (0.00%)
As of 02/4/2025 05:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ALNT vs. TRNS, CTKB, BNGO, SENS, LAB, EYPT, QTRX, AEHR, QSI, and NAUT

Should you be buying Allient stock or one of its competitors? The main competitors of Allient include Transcat (TRNS), Cytek Biosciences (CTKB), Bionano Genomics (BNGO), Senseonics (SENS), Standard BioTools (LAB), EyePoint Pharmaceuticals (EYPT), Quanterix (QTRX), Aehr Test Systems (AEHR), Quantum-Si (QSI), and Nautilus Biotechnology (NAUT). These companies are all part of the "measuring and control equipment" industry.

Allient vs.

Transcat (NASDAQ:TRNS) and Allient (NASDAQ:ALNT) are both small-cap computer and technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, valuation, community ranking, dividends, institutional ownership, profitability, analyst recommendations, earnings and risk.

98.3% of Transcat shares are owned by institutional investors. Comparatively, 61.6% of Allient shares are owned by institutional investors. 2.3% of Transcat shares are owned by company insiders. Comparatively, 15.6% of Allient shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Transcat has a net margin of 6.22% compared to Allient's net margin of 2.64%. Allient's return on equity of 10.80% beat Transcat's return on equity.

Company Net Margins Return on Equity Return on Assets
Transcat6.22% 7.43% 6.01%
Allient 2.64%10.80%4.75%

Transcat received 207 more outperform votes than Allient when rated by MarketBeat users. However, 66.67% of users gave Allient an outperform vote while only 66.14% of users gave Transcat an outperform vote.

CompanyUnderperformOutperform
TranscatOutperform Votes
211
66.14%
Underperform Votes
108
33.86%
AllientOutperform Votes
4
66.67%
Underperform Votes
2
33.33%

In the previous week, Transcat had 27 more articles in the media than Allient. MarketBeat recorded 30 mentions for Transcat and 3 mentions for Allient. Allient's average media sentiment score of 0.80 beat Transcat's score of 0.32 indicating that Allient is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Transcat
5 Very Positive mention(s)
6 Positive mention(s)
4 Neutral mention(s)
5 Negative mention(s)
0 Very Negative mention(s)
Neutral
Allient
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Allient has higher revenue and earnings than Transcat. Allient is trading at a lower price-to-earnings ratio than Transcat, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Transcat$259.48M2.81$13.65M$1.8542.86
Allient$578.63M0.72$24.10M$0.8828.00

Transcat currently has a consensus target price of $111.50, suggesting a potential upside of 40.61%. Allient has a consensus target price of $29.33, suggesting a potential upside of 19.05%. Given Transcat's higher probable upside, analysts clearly believe Transcat is more favorable than Allient.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Transcat
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40
Allient
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67

Transcat has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500. Comparatively, Allient has a beta of 1.61, meaning that its share price is 61% more volatile than the S&P 500.

Summary

Transcat beats Allient on 9 of the 17 factors compared between the two stocks.

Get Allient News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALNT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALNT vs. The Competition

MetricAllientInstruments to measure electricity IndustryComputer SectorNASDAQ Exchange
Market Cap$414.94M$4.62B$26.50B$9.11B
Dividend Yield0.48%0.44%2.73%4.00%
P/E Ratio28.0023.23238.0018.31
Price / Sales0.722.713,199.3081.15
Price / Cash6.5118.3736.2333.55
Price / Book1.594.178.634.76
Net Income$24.10M$144.73M$676.40M$223.10M
7 Day Performance-3.41%0.10%0.39%0.18%
1 Month Performance-3.79%-9.55%-0.36%-1.98%
1 Year Performance-10.89%3.61%27.55%23.41%

Allient Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALNT
Allient
4.2464 of 5 stars
$24.64
+0.9%
$29.33
+19.0%
-14.0%$414.94M$578.63M28.002,287Positive News
Gap Down
TRNS
Transcat
3.6106 of 5 stars
$99.31
-0.2%
$130.25
+31.2%
-29.8%$913.65M$259.48M50.161,104
CTKB
Cytek Biosciences
1.2118 of 5 stars
$5.73
-0.2%
$9.25
+61.4%
-31.2%$738.09M$201.21M-71.62500Short Interest ↓
BNGO
Bionano Genomics
2.5737 of 5 stars
$5.82
-20.2%
$90.00
+1,446.4%
-92.6%$680.47M$36.12M-2.51300Short Interest ↑
SENS
Senseonics
2.6725 of 5 stars
$1.06
-6.2%
$2.00
+88.7%
+68.5%$631.05M$22.39M-8.1590
LAB
Standard BioTools
3.1562 of 5 stars
$1.57
-4.8%
$2.88
+83.1%
-39.9%$584.45M$155.90M-2.21620
EYPT
EyePoint Pharmaceuticals
1.6573 of 5 stars
$8.02
-6.0%
$26.63
+232.0%
-73.4%$547.37M$46.02M-4.01120Short Interest ↑
QTRX
Quanterix
2.7147 of 5 stars
$9.58
+0.1%
$23.25
+142.7%
-63.5%$369.02M$122.37M-9.04460
AEHR
Aehr Test Systems
3.2783 of 5 stars
$11.88
-4.3%
$25.00
+110.4%
-26.4%$352.96M$66.22M15.8490Gap Down
QSI
Quantum-Si
2.6707 of 5 stars
$2.21
-3.9%
$3.25
+47.1%
+27.0%$315.40M$2.27M-3.45150Gap Up
NAUT
Nautilus Biotechnology
2.6495 of 5 stars
$1.84
-4.2%
$3.58
+94.7%
-35.6%$231.04MN/A-3.29130

Related Companies and Tools


This page (NASDAQ:ALNT) was last updated on 2/5/2025 by MarketBeat.com Staff
From Our Partners